Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
RGC stock price ended at $5.45 on 金曜日, after rising 4.01%
On the latest trading day Aug 14, 2026, the stock price of RGC rose by 4.01%, climbing from $5.24 to $5.45. Throughout the session, the stock experienced a volatility of 8.82%, with prices fluctuating between a daily low of $5.10 and a high of $5.55. Alongside this price increase, trading volume also rose by 34.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 132.2K shares were traded, amounting to a market value of approximately $2.7B.
Teknik analiz göstergeleri RGC için nasıl uygulanır?
Teknik analize göre, Regencell Bioscience Holdings Ltd Neutral toplam sinyaline sahiptir. Regencell Bioscience Holdings Ltd 3 adet al sinyali, 1 adet nötr sinyal ve 3 adet sat sinyali vardır.
RGC için Fibonacci geri dönüş seviyeleri nelerdir?
Regencell Bioscience Holdings Ltd için Fibonacci geri dönüş seviyesi 0%と23.6%の間dir。
Regencell Bioscience Holdings Ltd için RSI nedir?
Regencell Bioscience Holdings Ltd için mevcut RSI 46.36 'dir, bu da 中立 durumunu gösterir
Önümüzdeki 12 ay için Regencell Bioscience Holdings Ltd fiyatı nedir?
Regencell Bioscience Holdings Ltd RGC önümüzdeki 12 ay için $0 olarak tahmin edilmektedir.
Regencell Bioscience Holdings Ltd ne kadar yükselmesi bekleniyor?
Wall Street analistlerine göre, Regencell Bioscience Holdings Ltd $0 yüksek tahminine ulaşması beklenmektedir.